Determination of levodropropizine and its pharmacokinetics in human plasma using LC/MS/MS / 药学学报
Acta Pharmaceutica Sinica
;
(12): 993-996, 2004.
Article
Dans Chinois
| WPRIM
| ID: wpr-241375
ABSTRACT
<p><b>AIM</b>To develop a rapid and sensitive LC/MS/MS method for the analysis of levodropropizine in plasma and study the pharmacokinetics of levodropropizine in healthy Chinese volunteers.</p><p><b>METHODS</b>Levodropropizine and zolmitriptan (internal standard, IS) were extracted from plasma samples and chromatographed on a C18 column and detected using a tandem mass spectrometer with a TurboIon Spray ionization interface. Quantitation was performed using multiple reaction monitoring (MRM) of the transitions of the m/z 237 --> m/z 120 for levodropropizine and m/z 288 --> m/z 58 for the IS.</p><p><b>RESULTS</b>The limit of quantification of the method for levodropropizine was 0.25 microg x L(-1). The assay was linear over the concentration range from 0.25 to 500.0 microg x L(-1) and intra- and inter-day precision over this range were < 11.4% with good accuracy.</p><p><b>CONCLUSION</b>The method is shown to be accurate, and suitable for clinical pharmacokinetic study of levodropropizine.</p>
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
Sujet Principal:
Antitussifs
/
Propylène glycols
/
Sang
/
Pharmacocinétique
/
Administration par voie orale
/
Chromatographie en phase liquide
/
Aire sous la courbe
/
Spectrométrie de masse ESI
Type d'étude:
Étude pronostique
Limites du sujet:
Humains
/
Mâle
langue:
Chinois
Texte intégral:
Acta Pharmaceutica Sinica
Année:
2004
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS